• company
  • SLP concept
    • SLP therapy is synergistic
    • publications
  • technology
    • SLP technology
    • AMPLIVANT technology
  • pipeline
    • ISA101b (HPV16)
    • ISA103 (PRAME)
    • ISA104 (HBV)
    • ISA106 (SARS-CoV2)
    • MyISA®
  • clinical studies
  • partners
  • news archive
  • careers
  • contact

Interview with Prof. Cornelis Melief in the Novel Targets podcast

23 May 2016

Interview with Prof. Cornelis Melief in the latest episode of the Novel Targets podcast:

https://soundcloud.com/noveltargets/episode-12-of-mice-and-men
http://noveltargets.com/2016/05/episode-12-of-mice-and-men/

Previous ISA Pharmaceuticals obtains broad patent protection in the US for proprietary AMPLIVANT® platform and compounds
Next Interview with Prof. Cornelis Melief in the Novel Targets podcast
  • disclaimer
  • privacy statement

© 2019 Scicomvisuals, all rights reserved.

We use cookies to ensure that we give you the best experience on our website. Ok